NCT00884325

Management of Pruritus With Xyzal in Atopic Dermatitis

Management of Pruritus With Xyzal in Atopic Dermatitis in a Randomized, Double-Blind, Placebo Controlled Study

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Derm Research, PLLC · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

It is historically well known that the management of pruritus in atopic dermatitis is very difficult. Most of the patients are not controlled with traditional antihistamines such as Clarinex, Claritin, and Allegra. It will be a welcome addition to our treatment armamentarium if a drug such as Xyzal can control pruritus associated with atopic dermatitis.

Conditions

• Atopic Dermatitis
• Pruritus

Interventions

Type	Name	Description
DRUG	Levocetirizine dihydrochloride (Xyzal)	One tablet 5 mg taken orally at night for 28 days
DRUG	placebo	One tablet taken orally at night for 28 days

Timeline

• Start date: 2009-02-01
• Primary completion: 2010-01-01
• Completion: 2010-01-01
• First posted: 2009-04-20
• Last updated: 2013-08-16
• Results posted: 2013-08-16

Locations

1 site across 1 country: United States